Here, we report that PC-1/PrLZ conferred radio-resistance to prostate cancer cells and suppression of PC-1/PrLZ reduced cell repair of DNA double-strand breaks (DSBs) and attenuated activation of the G2 checkpoint. Here, TPD52 is linked to prostate cancer.